Premium
SARS‐CoV ‐2 virtual biochemistry labs on bioinformatics and drug design
Author(s) -
Brandt Gabriel S.,
Novak Walter R. P.
Publication year - 2020
Publication title -
biochemistry and molecular biology education
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.34
H-Index - 39
eISSN - 1539-3429
pISSN - 1470-8175
DOI - 10.1002/bmb.21480
Subject(s) - covid-19 , virtual lab , visualization , virtual screening , virtual learning environment , set (abstract data type) , computer science , software , pandemic , drug discovery , human–computer interaction , world wide web , multimedia , bioinformatics , medicine , virology , biology , artificial intelligence , infectious disease (medical specialty) , disease , pathology , outbreak , programming language
Colleges and universities are learning to provide relevant virtual lab experiences for students due to the COVID‐19 pandemic. Even schools attempting in‐person instruction often need to utilize virtual experiences for students absent due to quarantine or illness. Much of biochemistry is amenable to molecular visualization and/or computational study; however, many faculty face learning how to utilize new computational and molecular visualization software. We present a set of virtual lab exercises with detailed instructions to engage students in the discovery of novel antiviral compounds against the SARS‐CoV‐2 main protease.